Intuit, Container Store, Inovio Pharmaceuticals Stocks Moving Today

Inovio Pharmaceuticals is getting a huge boost thanks to positive trial results from its HIV vaccine

by Josh Selway

Published on May 24, 2017 at 2:38 PM

The Dow is maintaining its lead after the Fed meeting minutes showed most central bankers were comfortable with issuing another rate hike "soon." Among the names making big moves are TurboTax parent Intuit Inc. (NASDAQ:INTU), retailer Container Store Group Inc (NYSE:TCS), and drug stock Inovio Pharmaceuticals Inc (NASDAQ:INO). Here's a quick look at what's moving shares of INTU, TCS, and INO.

INTU Stock Rockets to New Highs After Earnings

Intuit stock is roaring up the charts today, earlier hitting a record high of $140.25, last seen up 7.5% at $138.81. This comes after the company posted impressive fiscal third-quarter earnings and an upbeat full-year outlook. The shares are now up 32% over the past 12 months, and analysts are quickly raising their price targets. Several brokerage firms have weighed in since yesterday's close, including Credit Suisse and Barclays, which each issued price-target hikes to $150. There very well could be additional bullish notes coming through in the near future, too, since just five of 14 brokerage firms recommend buying INTU stock. 

TCS Stock Surges on Restructuring Plan

Container Store stock is also rallying after earnings, up 28.9% at $5.35, making it the top percentage gainer on the NYSE at last check. The company also announced a restructuring plan to improve profitability. The shares are on pace for their first close above their 200-day moving average since mid-January, and they're back in positive year-over-year territory. Today's price action is crushing short sellers, who control 3.4 million shares -- or 27 times the average daily trading volume for TCS stock. 

INO Stock Up Big After HIV Vaccine Results

Inovio Pharmaceuticals stock has gapped atop its 200-day moving average, as well, surging 25.2% to $8.93, thanks to promising study results for the company's HIV vaccine. A price-target hike to $12 from $10 at Maxim is only stoking the bullish flames. Despite the huge move, INO shares remain well below their 52-week high of $11.62 from June. Meanwhile, it's an excellent time to buy premium on short-term INO options. This is according to INO stock's Schaeffer's Volatility Index (SVI) of 44% -- an annual low. 


START YOUR SATURDAY SMARTER.


The best of Schaeffer's market analysis in a 5-minute weekly read.


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.
Why Dermira, Menlo Therapeutics are Red-Hot Today
The broader stock market is much lower this afternoon, though
Banks, Blue Chips Kick Off Earnings Season
Dow earnings are expected to come in droves again next week
16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.